Abstract
As we look to a world where more individuals will suffer from dementia, it is important to reflect on our past accomplishments as we work to create a better future. Attempts to develop better medications for Alzheimer’s disease focus on symptomatic treatments for both cognitive and behavioral symptoms. Some progress has been made in the areas through use of cholinesterase inhibitors and novel neuroleptics. Quality of life is a central concept to improving our interventions and to developing more effective treatments based on our understanding of pathogenesis. In the past, almost hundred years since the pioneering work in Emil Kraepelin’s laboratory that we are celebrating in this series of papers, we have come far but we have further to go.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Whitehouse, P. Alzheimer’s disease: past, present, and future. European Archives of Psychiatry and Clinical Neurosciences 249 (Suppl 3), S43–S45 (1999). https://doi.org/10.1007/PL00014173
Issue Date:
DOI: https://doi.org/10.1007/PL00014173